NCT06617871

Brief Summary

Knee replacement surgery can be performed in one of two ways. Traditionally the goal was for the new joint to be in a neutral position with respect to the femur (thigh bone). This is called Mechanical Alignment (MA). The neutral position is different than the human knee's natural position, so MA often requires the surgeon to make additional cuts to the ligaments and other soft tissue around the knee. More recently surgeons have started to place the new joint in a position that more closely replicates the natural alignment of the human knee. This is called Kinemetic Alignment (KA). KA can be done without additional soft tissue dissection but the procedure requires a higher level of precision that can be difficult to achieve in every case. Some studies have found no difference in outcomes between MA and KA, whereas others have found KA to be superior. But these were small studies or studies that did not consider patient-rated outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
29mo left

Started Aug 2024

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Aug 2024Dec 2028

Study Start

First participant enrolled

August 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

3.9 years

First QC Date

September 25, 2024

Last Update Submit

March 20, 2026

Conditions

Keywords

randomized trialknee arthroplasty

Outcome Measures

Primary Outcomes (1)

  • 6-week Knee Injury and Osteoarthritis - Joint Replacement Score (KOOS-JR)

    The Knee Injury and Osteoarthritis Score - Joint Replacement (KOOS-JR) score; range: 0 (worst knee health) - 100 (perfect knee health)

    6 weeks postoperative

Secondary Outcomes (1)

  • Forgotten Joint Score (FJS)

    1 year postoperative

Study Arms (2)

Mechanical Alignment (MA)

ACTIVE COMPARATOR

Primary TKA with the Medacta SpheriKA, utilizing either MA methodology.

Procedure: Mechanical Alignment (MA)

Kinematic Alignment (KA)

ACTIVE COMPARATOR

Primary TKA with the Medacta SpheriKA, utilizing either KA methodology.

Procedure: Kinematic Alignment (KA) Interventions:

Interventions

Primary TKA with the Medacta SpheriKA, utilizing either KA methodology.

Kinematic Alignment (KA)

Primary TKA with the Medacta SpheriKA, utilizing either MA methodology.

Mechanical Alignment (MA)

Eligibility Criteria

Age21 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient undergoing primary TKA with a medially-stabilized SpheriKA knee system
  • Able to read and understand consent form and PRO instruments and willing to return for follow up visits

You may not qualify if:

  • Varus or Valgus malalignment \>15 degrees to mechanical axis
  • Flexion contracture \>15 degrees or flexion \<90 degrees
  • BMI \>40
  • Revision TKA or other prior knee surgery other than arthroscopy or arthroscopic-assisted ligament reconstruction
  • Diagnosis or history of any of the following
  • inflammatory arthritis
  • infection in study knee
  • chronic pain
  • chronic opioid use
  • metabolic musculoskeletal disorder other than osteopenia/osteoporosis
  • Patients receiving workers' compensation for study condition
  • Patients who cannot complete questionnaires in English
  • Patients with comorbidities preventing surgery
  • Patients who are not able to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Medicine

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Methods

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Adam Edelstein, MD

    Assistant Professor of Orthopaedic Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Megan VanDyke, BSN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1:1
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Orthopaedic Surgery

Study Record Dates

First Submitted

September 25, 2024

First Posted

October 1, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

March 24, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Aggregate data will be shared via ClinicalTrials.gov

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Supporting information will be available after all manuscripts have been published.
Access Criteria
Contact study PI

Locations